What's new
Last updated on Thursday, 13 February 2025 at 08:35pm
We regularly update the dashboard with new data and features. Here we'll show a timeline of changes that have happened outside of the weekly data refresh.
- Entry category: New metricEntry title: Antimicrobial resistance in E. coli bacteriuria added to the dashboard
More data has been added to the dashboard under the Antimicrobial Resistance (AMR) theme. This includes data for antimicrobial resistance to E. coli bacteriuria (bacteria in urine samples).
Timely monitoring of susceptibility test results for Escherichia coli (E. coli) supports the government’s 5-year action plan on confronting antimicrobial resistance.
Sharing this data will help to identify emerging trends in AMR. Antimicrobials presented in this metric have been selected due to their clinical importance when treating E. coli infections in urine specimens.
- Entry category: UpdateEntry title: Addition of measles into the Outbreaks section
Data for measles can now be found under both the Outbreaks and Vaccine-preventable diseases themes on the dashboard.
Measles activity in England has increased steadily since April 2025 and UKHSA is overseeing the public health risk assessment and response.
- Entry category: New metricEntry title: Heat exposure, sunburn and sunstroke metrics added to the dashboard
The dashboard now shows several indicators of syndromic surveillance data on cases of heat exposure, sunburn and sunstroke in England.
There is a new section called 'seasonal environmental conditions'.
Data showing the daily number of emergency department attendances, the daily GP in-hours consultation rate for and NHS 111 triaged calls are now available in the Syndromic Surveillance section of the dashboard.
- Entry category: Change to metricEntry title: Antimicrobial resistance (AMR) updated
Data showing antimicrobial resistance in E. coli bacteraemia has been expanded. It is now possible to see resistance to several further antimicrobials.
The time series of the data has also been extended and now goes back 5 years, to 2020.
Data is available for E.coli bacteraemia tested for resistance to the following:
- amikacin
- carbapenems
- third-generation cephalosporins
Timely monitoring of susceptibility test results for Escherichia coli (E. coli) supports the government’s 5-year action plan on confronting antimicrobial resistance.
- Entry category: Data issueEntry title: Correction to COVID-19 case rates data
As the result of a systematic error in reference data containing population estimates, 7-day rolling-average COVID-19 case rates were incorrectly calculated. The error appeared on 10 April and was resolved on 28 April, with the corrected metrics released at 4pm.
During this period, all case rates appeared as half their expected value. This affected users interacting with the Case rates by specimen date (7-day rolling average) and Case rates by specimen date and sex (7-day rolling average) charts, downloading the corresponding data or accessing these metrics using our API or by other automated means.
Overall trends in COVID-19 case rates remain unaffected. Other COVID-19 metrics including case numbers, testing numbers, positivity, hospital admissions and deaths also remain unaffected.
We have taken steps to improve our data quality processes to help prevent similar issues occurring in the future.
- Entry category: New metricEntry title: Lead exposure in children data added to dashboard
The dashboard now shows data on cases of lead exposure in children in England.
The data is taken from the latest annual report from the Lead Exposure in Children Surveillance System (LEICSS). The system notifies UKHSA of incidents of elevated blood lead concentration in children aged 0 to 15 years.
Lead is a persistent, heavy metal environmental contaminant. It has an adverse effect on the body even at low blood level concentration. There is no known safe threshold for lead exposure in children. Children and pregnant women are particularly vulnerable.
- Entry category: Change to metricEntry title: Surveillance of hospitalisations due to RSV paused
Surveillance of hospitalisations due to RSV is now paused for the 2024 to 2025 season. Hospital admissions rate data will not be updated until surveillance is resumed for the next season.
- Entry category: New metricEntry title: Scarlet fever data added to dashboard
Data showing several indicators for scarlet fever is now available on the dashboard.
Data showing the daily number of emergency department attendances and the daily GP in-hours consultation rate for scarlet fever is now available in the Syndromic Surveillance section of the dashboard.
There is a new section called 'Childhood and vaccine-preventable illnesses'. This includes data showing the GP in-hours weekly consultation rate for scarlet fever.
Scarlet fever is an illness that mainly affects children. It occurs most often in the winter and spring. Symptoms include a rash, a sore throat, flushed cheeks and swollen tongue. Scarlet fever is caused by Streptococcus pyogenes or group A streptococci (GAS) bacteria. Occasionally these bacteria can cause severe and life-threatening diseases.
- Entry category: New metricEntry title: Hepatitis C in England data added to dashboard
Data showing hepatitis C (HCV) in England is now available.
This includes the number of people estimated to be living with hepatitis C, proportion of individuals tested and hepatitis C deaths, along with other metrics.
Multiple sources of data are used to track progress over time. More information can be found in the metric documentation.
The Hepatitis C virus affects the liver. It is a major public health threat in the UK.
- Entry category: New metricEntry title: Invasive Group A Streptococcus (iGAS) infections in England data added to dashboard
Data showing Invasive Group A Streptococcus (iGAS) infections in England has been added to the dashboard.
The dashboard now shows the weekly count and the monthly rate per 100,000 population of iGAS cases.
Cases of iGAS are formally diagnosed from positive microbiological diagnostic test results. All positive samples are reported to the UKHSA Second Generation Surveillance System (SGSS).
Group A Streptococcus (also known as GAS, group A strep, strep A, and Streptococcus pyogenes) is a bacterium which can colonise the throat, skin and anogenital tract.